Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Therapeutische Umschau. Revue Therapeutique
|
October 5, 2011
[Fertility preservation and pregnancy in gynecological cancers]
Rosanna Zanetti Dällenbach, Olav Lapaire
Expert Opinion on Medical Diagnostics
|
March 14, 2013
Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges
Sinuhe Hahn, Irene Hösli, Olav Lapaire
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 12, 2010
The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application
Olav Lapaire, Andrew Shennan, Holger Stepan
Biomarkers in Medicine
|
May 7, 2014
What does next-generation sequencing mean for prenatal diagnosis?
Gwendolin Manegold-Brauer, Sinuhe Hahn, Olav Lapaire
Expert Review of Molecular Diagnostics
|
March 17, 2015
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
Sinuhe Hahn, Olav Lapaire, Nandor Gabor Than
Expert Opinion on Medical Diagnostics
|
March 14, 2013
Cell-free fetal nucleic acids as prenatal biomarkers
Eva Visca, Olav Lapaire, Irene Hösli, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 22, 2008
Method for extraction of high-quantity and -quality cell-free DNA from amniotic fluid
Olav Lapaire, Kirby L Johnson, Diana W Bianchi
BMJ Case Reports
|
April 18, 2015
Unresponsive primipara after rupture of membranes
Johanna Buechel, Andreas Berset, Michael A Lehmann, et al.
Therapeutische Umschau. Revue Therapeutique
|
November 4, 2008
[Gestational diabetes - practical approach in the clinic]
Olav Lapaire, Evelyn Huhn, Moritz Hartog, et al.
Journal of Medical Economics
|
May 29, 2020
Preeclampsia in Switzerland: a cost analysis in two hospitals
Markus Hodel, Patricia R Blank, Petra Marty, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Therapeutische Umschau. Revue Therapeutique
|
October 5, 2011
[Fertility preservation and pregnancy in gynecological cancers]
Rosanna Zanetti Dällenbach, Olav Lapaire
Expert Opinion on Medical Diagnostics
|
March 14, 2013
Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges
Sinuhe Hahn, Irene Hösli, Olav Lapaire
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 12, 2010
The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application
Olav Lapaire, Andrew Shennan, Holger Stepan
Biomarkers in Medicine
|
May 7, 2014
What does next-generation sequencing mean for prenatal diagnosis?
Gwendolin Manegold-Brauer, Sinuhe Hahn, Olav Lapaire
Expert Review of Molecular Diagnostics
|
March 17, 2015
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
Sinuhe Hahn, Olav Lapaire, Nandor Gabor Than
Expert Opinion on Medical Diagnostics
|
March 14, 2013
Cell-free fetal nucleic acids as prenatal biomarkers
Eva Visca, Olav Lapaire, Irene Hösli, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 22, 2008
Method for extraction of high-quantity and -quality cell-free DNA from amniotic fluid
Olav Lapaire, Kirby L Johnson, Diana W Bianchi
BMJ Case Reports
|
April 18, 2015
Unresponsive primipara after rupture of membranes
Johanna Buechel, Andreas Berset, Michael A Lehmann, et al.
Therapeutische Umschau. Revue Therapeutique
|
November 4, 2008
[Gestational diabetes - practical approach in the clinic]
Olav Lapaire, Evelyn Huhn, Moritz Hartog, et al.
Journal of Medical Economics
|
May 29, 2020
Preeclampsia in Switzerland: a cost analysis in two hospitals
Markus Hodel, Patricia R Blank, Petra Marty, et al.
Page
of 10